BostonGene, a developer of the leading AI foundation model for tumor and immune biology, today announced that 13 abstracts have been selected for presentation at the American Association for Cancer ...
Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced that the first cohort of healthy volunteers has been ...
Professor Gyu Rie Lee of the Department of Biological Sciences successfully designed artificial proteins that selectively ...
US Food and Drug Administration (FDA) officials credited recent advancements in regulatory science and flexibilities with ...
Publication strengthens NetraMark's case for biomarker-guided enrichment, individualized response modeling, and explainable AI for trial design in psychedelic clinical development. TORONTO, April 09, ...
Nancy L. Lewis, MD, MBS, FACP, reflects on the career journey that led her to her new role as chief scientific officer (CSO) ...
Lynk Pharmaceuticals Co., Ltd. ('Lynk Pharmaceuticals'), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today announced that the New ...
A research team led by Prof. Sangwon Seo of the Department of Physics and Chemistry at DGIST has developed a catalytic ...
New drugs, enhanced treatment approaches and a better understanding of root causes may help to slow down or stop the disease ...
For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...
This new Aramchol formulation was co-developed by Galmed and Barcode Nanotech, based on Barcode Nanotech's unique and proprietary platform which enables simultaneous screening of hundreds of different ...
For the past year, the pharmaceutical industry has wrestled with Washington, as President Donald Trump has demanded that drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results